000 | 03501cam a22004338i 4500 | ||
---|---|---|---|
001 | 21766327 | ||
003 | KENaKMTC | ||
005 | 20230201100501.0 | ||
006 | m |o d | | ||
007 | cr ||||||||||| | ||
008 | 201021s2021 flu ob 001 0 eng | ||
010 | _a 2020047766 | ||
020 |
_a9780853698357 _q(ebook) |
||
020 |
_z9780853698357 _q(hardcover) |
||
040 |
_aDLC _beng _cKENKMTC _erda |
||
042 | _apcc | ||
050 | 0 | 0 |
_aRM301.25 _b2009 |
060 | 0 | 0 | _aQV 241 |
082 | 0 | 0 |
_a615.1/9 _223 |
245 | 0 | 0 |
_aApplied pharmaceutical practice and nutraceuticals : _bnatural product developments / _cedited by Debarshi Kar Mahapatra, Cristóbal Noé Aguilar, A.K. Haghi. |
250 | _aFirst edition. | ||
260 |
_aLondon _bPharmaceutical Press _c2009 |
||
263 | _a2102 | ||
300 | _a1 online resource | ||
504 | _aIncludes bibliographical references and index. | ||
520 | _a"Applied Pharmaceutical Practice and Nutraceuticals: Natural Product Developments showcases how pharmaceutical and nutraceutical compounds from natural products can be used to cure or prevent diseases. The chapters explore the connections between agrochemicals and pharmaceuticals and the use of plants and plant products in the formulation and development of new pharmaceuticals and nutraceuticals. The pharmaceutical industry recognizes the shift to the use of natural products while also considering the serious concerns that have arisen regarding the claimed efficacy, quality, and safety of these products. Chapters cover: The emerging perspectives of natural chalcone-based nitric acid inhibitors The pharmacological properties of Emblicanin-A and Emblicanin-B constituents found in Phyllanthus emblica The pathophysiology and various herbal drugs used for treating helminthiasis (or worm infections) and their pharmacological activities Natural medicines that can be employed as diuretics The utilization, safety, and therapeutic perspectives of medicinal plant for treating psoriasis and skin diseases The role of nutrients and cofactors, dietary adjustments and gut anomalies, probiotics and prebiotics, phytochemicals, and ecological factors for evaluating the condition of proof in nutraceutical-based disease management practices Beer as a major source of compounds associated with health benefits, which could possibly decrease the risks of cardiovascular disease The role of the media as an important source of health information to help with personal medical decisions, specifically regarding cancer The composition of Artemisia herba-alba and Origanum majorana essential oils is analyzed, and their antibacterial and antifungal activity How medicinal plants and herbs combined with some kinds of alcohol develop healing, stimulating, and aphrodisiac effects while others can cause adverse effects and allergies"-- | ||
650 | 1 | 2 |
_aBiological Products _xpharmacology |
650 | 1 | 2 |
_aBiological Products _xtherapeutic use |
650 | 2 | 2 | _aDietary Supplements |
650 | 2 | 2 |
_aDrug Discovery _xmethods |
650 | 2 | 2 | _aDrug Therapy |
700 | 1 |
_aMahapatra, Debarshi Kar, _eeditor. |
|
700 | 1 |
_aAguilar, Cristóbal Noé, _eeditor. |
|
700 | 1 |
_aHaghi, A. K., _eeditor. |
|
776 | 0 | 8 |
_iPrint version: _tApplied pharmaceutical practice and nutraceuticals _bFirst edition. _dPalm Bay, FL : Apple Academic Press, [2021] _z9781771889247 _w(DLC) 2020047765 |
906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
942 |
_2lcc _cBK _e1st Edition _hRM301.25 _i2009 _xKM |
||
999 |
_c13529 _d13529 |